A Pilot Study of the Combination of Retinoic Acid and Interferon-Alpha2a for the Treatment of Lymphoproliferative Disorders in Children With Immunodeficiency Syndromes

This study has been completed.

Study NCT00001438 Information provided by National Institutes of Health Clinical Center (CC)

First Received: November 3, 1999 Last Updated: March 3, 2008 History of Changes

No Study Results Posted for this Study

Study Status:	This study has been completed.
Estimated Study Completion Date:	December 2000
Estimated Primary Completion Date:	No date given